{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:11Z","timestamp":1793364011679,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03004-9","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:30:31Z","timestamp":1755865831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation"],"prefix":"10.1007","volume":"42","author":[{"given":"Negin","family":"Taghehchian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Akhlaghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Sadra","family":"Zangouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Palizkaran Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Moghbeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"5","key":"3004_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12032-022-01677-0","volume":"39","author":"P Sharma","year":"2022","unstructured":"Sharma P, Jhawat V, Mathur P, Dutt R. Innovation in cancer therapeutics and regulatory perspectives. Med Oncol. 2022;39(5):76.","journal-title":"Med Oncol"},{"issue":"1","key":"3004_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13008-023-00093-8","volume":"18","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells. Cell Div. 2023;18(1):11.","journal-title":"Cell Div"},{"issue":"1","key":"3004_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","volume":"37","author":"G Kibria","year":"2014","unstructured":"Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharm Res. 2014;37(1):4\u201315.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"3004_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12935-021-01873-4","volume":"21","author":"AS Zangouei","year":"2021","unstructured":"Zangouei AS, Alimardani M, Moghbeli M. Micrornas as the critical regulators of doxorubicin resistance in breast tumor cells. Cancer Cell Int. 2021;21(1):213.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3004_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S, Malik F. Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal. 2024;22(1): 109.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3004_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-019-1876-5","volume":"17","author":"M Moghbeli","year":"2019","unstructured":"Moghbeli M, Mosannen Mozaffari H, Memar B, Forghanifard MM, Gholamin M, Abbaszadegan MR. Role of MAML1 in targeted therapy against the esophageal cancer stem cells. J Transl Med. 2019;17(1):126.","journal-title":"J Transl Med"},{"issue":"5","key":"3004_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clin Exp Metas. 2022;39(5):715\u201326.","journal-title":"Clin Exp Metas"},{"key":"3004_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108522","volume":"250","author":"SU Khan","year":"2023","unstructured":"Khan SU, Fatima K, Malik F, Kalkavan H, Wani A. Cancer metastasis: molecular mechanisms and clinical perspectives. Pharmacol Ther. 2023;250: 108522.","journal-title":"Pharmacol Ther"},{"key":"3004_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquatox.2020.105656","volume":"229","author":"BF Karas","year":"2020","unstructured":"Karas BF, Hotz JM, Buckley BT, Cooper KR. Cisplatin alkylating activity in zebrafish causes resistance to chorionic degradation and inhibition of osteogenesis. Aquat Toxicol. 2020;229: 105656.","journal-title":"Aquat Toxicol"},{"issue":"1","key":"3004_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41021-021-00192-4","volume":"43","author":"AS Zangouei","year":"2021","unstructured":"Zangouei AS, Moghbeli M. Micrornas as the critical regulators of cisplatin resistance in gastric tumor cells. Gen Environ\u202f: Off Japanese Environ Mutagen Soc. 2021;43(1):21.","journal-title":"Gen Environ : Off Japanese Environ Mutagen Soc"},{"issue":"1","key":"3004_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00882-1","volume":"14","author":"M Moghbeli","year":"2021","unstructured":"Moghbeli M. Micrornas as the critical regulators of Cisplatin resistance in ovarian cancer cells. J Ovarian Res. 2021;14(1): 127.","journal-title":"J Ovarian Res"},{"issue":"4","key":"3004_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.32604\/or.2022.025323","volume":"29","author":"ZN Navaei","year":"2021","unstructured":"Navaei ZN, Khalili-Tanha G, Zangouei AS, Abbaszadegan MR, Moghbeli M. PI3K\/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. Oncol Res. 2021;29(4):235\u201350.","journal-title":"Oncol Res"},{"key":"3004_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175937","volume":"956","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells. Eur J Pharmacol. 2023;956: 175937.","journal-title":"Eur J Pharmacol"},{"key":"3004_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030463","author":"J Xu","year":"2022","unstructured":"Xu J, Gewirtz DA. Is autophagy always a barrier to Cisplatin therapy? Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12030463.","journal-title":"Biomolecules"},{"key":"3004_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154743","volume":"249","author":"M Moghbeli","year":"2023","unstructured":"Moghbeli M. Micrornas as the pivotal regulators of cisplatin resistance in osteosarcoma. Pathol - Res Pract. 2023;249: 154743.","journal-title":"Pathol - Res Pract"},{"issue":"4","key":"3004_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/gcc.22032","volume":"52","author":"E Zandberga","year":"2013","unstructured":"Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer. 2013;52(4):356\u201369.","journal-title":"Genes Chromosomes Cancer"},{"issue":"15","key":"3004_CR17","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"issue":"1","key":"3004_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12935-023-02925-7","volume":"23","author":"F Tolue Ghasaban","year":"2023","unstructured":"Tolue Ghasaban F, Maharati A, Akhlaghipour I, Moghbeli M. Micrornas as the critical regulators of autophagy-mediated cisplatin response in tumor cells. Cancer Cell Int. 2023;23(1):80.","journal-title":"Cancer Cell Int"},{"key":"3004_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175937","volume":"956","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells. Eur J Pharmacol. 2023;956: 175937.","journal-title":"Eur J Pharmacol"},{"issue":"54","key":"3004_CR20","doi-asserted-by":"publisher","first-page":"92743","DOI":"10.18632\/oncotarget.21574","volume":"8","author":"K Carter","year":"2017","unstructured":"Carter K, Rameshwar P, Ratajczak MZ, Kakar SS. Verrucarin j inhibits ovarian cancer and targets cancer stem cells. Oncotarget. 2017;8(54):92743\u201356.","journal-title":"Oncotarget"},{"issue":"4","key":"3004_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/0022034520965141","volume":"100","author":"T Nakano","year":"2021","unstructured":"Nakano T, Warner KA, Oklejas AE, Zhang Z, Rodriguez-Ramirez C, Shuman AG, et al. mTOR inhibition ablates cisplatin-resistant salivary gland cancer stem cells. J Dent Res. 2021;100(4):377\u201386.","journal-title":"J Dent Res"},{"issue":"2","key":"3004_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1593\/neo.131744","volume":"16","author":"C Nor","year":"2014","unstructured":"Nor C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, et al. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia. 2014;16(2):137\u201346.","journal-title":"Neoplasia"},{"issue":"2","key":"3004_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","volume":"39","author":"T Schaefer","year":"2020","unstructured":"Schaefer T, Lengerke C. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond. Oncogene. 2020;39(2):278\u201392.","journal-title":"Oncogene"},{"issue":"1","key":"3004_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1101\/gad.224503","volume":"17","author":"AA Avilion","year":"2003","unstructured":"Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003;17(1):126\u201340.","journal-title":"Genes Dev"},{"issue":"1","key":"3004_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2001-1326-3-19","volume":"3","author":"K Weina","year":"2014","unstructured":"Weina K, Utikal J. SOX2 and cancer: current research and its implications in the clinic. Clin Transl Med. 2014;3(1):1\u201310.","journal-title":"Clin Transl Med"},{"issue":"5","key":"3004_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1195","volume":"8","author":"F Cui","year":"2020","unstructured":"Cui F, Hao Zx, Li J, Zhang Yl, Li Xk, He Jx. SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p. Mol Genet Genomic Med. 2020;8(5): e1195.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"3004_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1195","volume":"8","author":"F Cui","year":"2020","unstructured":"Cui F, Hao ZX, Li J, Zhang YL, Li XK, He JX. SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p. Mol Genet Genomic Med. 2020;8(5): e1195.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"3004_CR28","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/mmr.2017.6170","volume":"15","author":"J He","year":"2017","unstructured":"He J, Shi J, Zhang K, Xue J, Li J, Yang J, et al. Sox2 inhibits Wnt-beta-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells. Mol Med Rep. 2017;15(4):1693\u2013701.","journal-title":"Mol Med Rep"},{"issue":"2","key":"3004_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jmcb\/mjy080","volume":"12","author":"MA Mamun","year":"2020","unstructured":"Mamun MA, Mannoor K, Cao J, Qadri F, Song X. SOX2 in cancer stemness: tumor malignancy and therapeutic potentials. J Mol Cell Biol. 2020;12(2):85\u201398.","journal-title":"J Mol Cell Biol"},{"key":"3004_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, et al. SOX2 function in cancers: association with growth, invasion, stemness and therapy response. Biomed Pharmacother. 2022;156: 113860.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3004_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/carcin\/bgt410","volume":"35","author":"K Hutz","year":"2014","unstructured":"Hutz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S, Anton M, et al. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis. 2014;35(4):942\u201350.","journal-title":"Carcinogenesis"},{"issue":"5","key":"3004_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.7555\/JBR.26.20120045","volume":"26","author":"T Tian","year":"2012","unstructured":"Tian T, Zhang Y, Wang S, Zhou J, Xu S. Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res. 2012;26(5):336\u201345.","journal-title":"J Biomed Res"},{"issue":"1","key":"3004_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01225-x","volume":"21","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. PI3K\/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell Commun Signal. 2023;21(1): 201.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"3004_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","volume":"4","author":"D Wang","year":"2005","unstructured":"Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discovery. 2005;4(4):307\u201320.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"3004_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1574362409666140206222746","volume":"8","author":"A Kornakiewicz","year":"2013","unstructured":"Kornakiewicz A, Solarek W, ZBielecka F, LianSzczylikCzarnecka FCMA. Mammalian target of rapamycin inhibitors resistance mechanisms in clear cell renal cell carcinoma. Curr Signal Transduct Ther. 2013;8(3):210\u20138.","journal-title":"Curr Signal Transduct Ther"},{"issue":"2","key":"3004_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"41","key":"3004_CR37","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.1073\/pnas.0702596104","volume":"104","author":"J Zhou","year":"2007","unstructured":"Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, et al. Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci. 2007;104(41):16158\u201363.","journal-title":"Proc Natl Acad Sci"},{"key":"3004_CR38","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s13277-015-4341-y","volume":"37","author":"L-X Xie","year":"2016","unstructured":"Xie L-X, Sun F-F, He B-F, Zhan X-F, Song J, Chen S-S, et al. Rapamycin inhibited the function of lung CSCs via SOX2. Tumor Biol. 2016;37:4929\u201337.","journal-title":"Tumor Biol"},{"issue":"7","key":"3004_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1089\/thy.2012.0372","volume":"23","author":"V Carina","year":"2013","unstructured":"Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, Rodolico V, et al. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Thyroid. 2013;23(7):829\u201337.","journal-title":"Thyroid"},{"issue":"1","key":"3004_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.critrevonc.2004.09.004","volume":"53","author":"WG Jiang","year":"2005","unstructured":"Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol. 2005;53(1):35\u201369.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"3004_CR41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"M Prince","year":"2007","unstructured":"Prince M, Sivanandan R, Kaczorowski A, Wolf G, Kaplan M, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci. 2007;104(3):973\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"3004_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.oraloncology.2014.04.004","volume":"50","author":"YC Lim","year":"2014","unstructured":"Lim YC, Kang HJ, Moon JH. C-met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell. Oral Oncol. 2014;50(7):633\u20139.","journal-title":"Oral Oncol"},{"issue":"10","key":"3004_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003360","volume":"3","author":"B Mack","year":"2008","unstructured":"Mack B, Gires O. CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE. 2008;3(10): e3360.","journal-title":"PLoS ONE"},{"issue":"5","key":"3004_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0955-0674(00)00135-6","volume":"12","author":"JY Lee","year":"2000","unstructured":"Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol. 2000;12(5):581\u20136.","journal-title":"Curr Opin Cell Biol"},{"issue":"39","key":"3004_CR45","doi-asserted-by":"publisher","first-page":"32800","DOI":"10.1074\/jbc.M111.308528","volume":"287","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon LY, Wong G, Earle C, Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012;287(39):32800\u201324.","journal-title":"J Biol Chem"},{"issue":"2","key":"3004_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/BJ20101569","volume":"434","author":"M Ni","year":"2011","unstructured":"Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochemical Journal. 2011;434(2):181\u20138.","journal-title":"Biochemical Journal"},{"issue":"4","key":"3004_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc3701","volume":"14","author":"AS Lee","year":"2014","unstructured":"Lee AS. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer. 2014;14(4):263\u201376.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3004_CR48","first-page":"1602","volume":"5","author":"P Xia","year":"2015","unstructured":"Xia P, Xu X-Y. PI3K\/Akt\/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015;5(5):1602.","journal-title":"Am J Cancer Res"},{"issue":"8","key":"3004_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/md18080399","volume":"18","author":"C-H Liao","year":"2020","unstructured":"Liao C-H, Tzeng Y-T, Lai G-M, Chang C-L, Hu M-H, Tsai W-L, et al. Omega-3 fatty acid-enriched fish oil and selenium combination modulates endoplasmic reticulum stress response elements and reverses acquired gefitinib resistance in HCC827 lung adenocarcinoma cells. Mar Drugs. 2020;18(8):399.","journal-title":"Mar Drugs"},{"issue":"4","key":"3004_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molcel.2012.08.030","volume":"48","author":"Y Lin","year":"2012","unstructured":"Lin Y, Yang Y, Li W, Chen Q, Li J, Pan X, et al. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol Cell. 2012;48(4):627\u201340.","journal-title":"Mol Cell"},{"issue":"14","key":"3004_CR51","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.3390\/ijms21144902","volume":"21","author":"T Schaefer","year":"2020","unstructured":"Schaefer T, Steiner R, Lengerke C. SOX2 and p53 expression control converges in PI3K\/AKT signaling with versatile implications for stemness and cancer. Int J Mol Sci. 2020;21(14):4902.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3004_CR52","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/sj.onc.1209071","volume":"25","author":"K Zu","year":"2006","unstructured":"Zu K, Bihani T, Lin A, Park Y, Mori K, Ip C. Enhanced selenium effect on growth arrest by BiP\/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene. 2006;25(4):546\u201354.","journal-title":"Oncogene"},{"issue":"6","key":"3004_CR53","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3892\/or.2014.3147","volume":"31","author":"W Li","year":"2014","unstructured":"Li W, Wang W, Dong H, Li Y, Li L, Han L, et al. Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78. Oncol Rep. 2014;31(6):2525\u201334.","journal-title":"Oncol Rep"},{"issue":"11","key":"3004_CR54","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3390\/biomedicines10112703","volume":"10","author":"N Sriratanasak","year":"2022","unstructured":"Sriratanasak N, Chunhacha P, Ei ZZ, Chanvorachote P. Cisplatin induces senescent lung cancer cell-mediated stemness induction via GRP78\/Akt-dependent mechanism. Biomedicines. 2022;10(11):2703.","journal-title":"Biomedicines"},{"issue":"1","key":"3004_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Chen R, Fu H-H, Montagna M, Schwartz PE, Rutherford T, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle. 2009;8(1):158\u201366.","journal-title":"Cell Cycle"},{"issue":"6","key":"3004_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ctrv.2012.03.003","volume":"38","author":"MR Alison","year":"2012","unstructured":"Alison MR, Lin W-R, Lim SM, Nicholson LJ. Cancer stem cells: in the line of fire. Cancer Treat Rev. 2012;38(6):589\u201398.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"3004_CR57","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326.","journal-title":"Nat Rev Cancer"},{"key":"3004_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0636-8","volume":"36","author":"B Thakur","year":"2017","unstructured":"Thakur B, Ray P. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-\u03baB-TNF\u03b1-PIK3CA loop. J Exp Clin Cancer Res. 2017;36:1\u201314.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3004_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00840-4","volume":"20","author":"A Maharati","year":"2022","unstructured":"Maharati A, Zanguei AS, Khalili-Tanha G, Moghbeli M. Micrornas as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells. Cell Commun Signal. 2022;20(1): 27.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"3004_CR60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/1878-0261.12875","volume":"15","author":"AM Herrera-Solorio","year":"2021","unstructured":"Herrera-Solorio AM, Peralta-Arrieta I, Armas Lopez L, Hern\u00e1ndez-Cigala N, Mendoza Milla C, Ortiz Quintero B, et al. LncRNA SOX2-OT regulates AKT\/ERK and SOX2\/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases. Mol Oncol. 2021;15(4):1110\u201329.","journal-title":"Mol Oncol"},{"key":"3004_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BFb0049776","volume":"126","author":"J Wilson","year":"2006","unstructured":"Wilson J. Hexokinases. Rev Physiol Biochem Pharmacol. 2006;126:65\u2013198.","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"3004_CR62","doi-asserted-by":"publisher","first-page":"153303381987130","DOI":"10.1177\/1533033819871306","volume":"18","author":"C Liu","year":"2019","unstructured":"Liu C, Wang X, Zhang Y. The roles of HK2 on tumorigenesis of cervical cancer. Technol Cancer Res Treat. 2019;18:1533033819871306.","journal-title":"Technol Cancer Res Treat"},{"key":"3004_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.581208","volume":"10","author":"N Cui","year":"2020","unstructured":"Cui N, Li L, Feng Q, Ma H-m, Lei D, Zheng P-S. Hexokinase 2 promotes cell growth and tumor formation through the Raf\/MEK\/ERK signaling pathway in cervical cancer. Front Oncol. 2020;10: 581208.","journal-title":"Front Oncol"},{"key":"3004_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.794015","volume":"11","author":"H Yang","year":"2021","unstructured":"Yang H, Hou H, Zhao H, Yu T, Hu Y, Hu Y, et al. HK2 is a crucial downstream regulator of miR-148a for the maintenance of sphere-forming property and cisplatin resistance in cervical cancer cells. Front Oncol. 2021;11: 794015.","journal-title":"Front Oncol"},{"issue":"12","key":"3004_CR65","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915\u201328.","journal-title":"Nat Rev Cancer"},{"key":"3004_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2015.00059","volume":"6","author":"SM Farabaugh","year":"2015","unstructured":"Farabaugh SM, Boone DN, Lee AV. Role of IGF1R in breast cancer subtypes, stemness, and lineage differentiation. Front Endocrinol. 2015;6:59.","journal-title":"Front Endocrinol"},{"issue":"7","key":"3004_CR67","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.18632\/oncotarget.3023","volume":"6","author":"L Taliaferro-Smith","year":"2015","unstructured":"Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, et al. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget. 2015;6(7):4757.","journal-title":"Oncotarget"},{"issue":"2","key":"3004_CR68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1254\/jphs.CRJ05006X","volume":"99","author":"A Wada","year":"2005","unstructured":"Wada A, Yokoo H, Yanagita T, Kobayashi H. New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J Pharmacol Sci. 2005;99(2):128\u201343.","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"3004_CR69","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1128\/MCB.01315-06","volume":"27","author":"H-J Kim","year":"2007","unstructured":"Kim H-J, Litzenburger BC, Cui X, Delgado DA, Grabiner BC, Lin X, et al. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-\u03baB and snail. Mol Cell Biol. 2007;27(8):3165\u201375.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3004_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-65006-z","volume":"10","author":"Y-F Chiu","year":"2020","unstructured":"Chiu Y-F, Wu C-C, Kuo M-H, Miao C-C, Zheng M-Y, Chen P-Y, et al. Critical role of SOX2\u2013IGF2 signaling in aggressiveness of bladder cancer. Sci Rep. 2020;10(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"2","key":"3004_CR71","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.stemcr.2017.12.003","volume":"10","author":"Y-C Kuo","year":"2018","unstructured":"Kuo Y-C, Au H-K, Hsu J-L, Wang H-F, Lee C-J, Peng S-W, et al. IGF-1R promotes symmetric self-renewal and migration of alkaline phosphatase+ germ stem cells through HIF-2\u03b1-OCT4\/CXCR4 loop under hypoxia. Stem Cell Reports. 2018;10(2):524\u201337.","journal-title":"Stem Cell Reports"},{"issue":"3","key":"3004_CR72","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/hep.25745","volume":"56","author":"J Shan","year":"2012","unstructured":"Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, et al. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology. 2012;56(3):1004\u201314.","journal-title":"Hepatology"},{"key":"3004_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215861","volume":"548","author":"L Zhou","year":"2022","unstructured":"Zhou L, Li H, Sun T, Wen X, Niu C, Li M, et al. HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance. Cancer Lett. 2022;548: 215861.","journal-title":"Cancer Lett"},{"issue":"19","key":"3004_CR74","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1111\/febs.16091","volume":"289","author":"H Kwon","year":"2022","unstructured":"Kwon H, Kim J, Jho Eh. Role of the hippo pathway and mechanisms for controlling cellular localization of YAP\/TAZ. FEBS J. 2022;289(19):5798\u2013818.","journal-title":"FEBS J"},{"issue":"16","key":"3004_CR75","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1002\/cam4.2569","volume":"8","author":"Y Chai","year":"2019","unstructured":"Chai Y, Li Q, Zhao H, Zhang Z, Yu X, Pang L, et al. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma. Cancer Med. 2019;8(16):7055\u201364.","journal-title":"Cancer Med"},{"issue":"6","key":"3004_CR76","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120\u201333.","journal-title":"Cell"},{"issue":"21","key":"3004_CR77","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747\u201361.","journal-title":"Genes Dev"},{"issue":"2","key":"3004_CR78","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan K-L. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3004_CR79","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","volume":"25","author":"B Aryal","year":"2019","unstructured":"Aryal B, Price NL, Suarez Y, Fern\u00e1ndez-Hernando C. ANGPTL4 in metabolic and cardiovascular disease. Trends Mol Med. 2019;25(8):723\u201334.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3004_CR80","first-page":"8187235","volume":"2017","author":"L La Paglia","year":"2017","unstructured":"La Paglia L, List\u00ec A, Caruso S, Amodeo V, Passiglia F, Bazan V, et al. Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway. PPAR Res. 2017;2017(1):8187235.","journal-title":"PPAR Res"},{"issue":"3","key":"3004_CR81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3892\/or.2020.7647","volume":"44","author":"S Zhou","year":"2020","unstructured":"Zhou S, Wang R, Xiao H. Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4. Oncol Rep. 2020;44(3):927\u201338.","journal-title":"Oncol Rep"},{"issue":"22","key":"3004_CR82","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.3390\/ijms20225625","volume":"20","author":"Y-T Tsai","year":"2019","unstructured":"Tsai Y-T, Wu A-C, Yang W-B, Kao T-J, Chuang J-Y, Chang W-C, et al. Angptl4 induces TMZ resistance of glioblastoma by promoting cancer stemness enrichment via the EGFR\/AKT\/4E-BP1 cascade. Int J Mol Sci. 2019;20(22):5625.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3004_CR83","first-page":"5632164","volume":"2022","author":"C Li","year":"2022","unstructured":"Li C, Wang Q, Luo Y, Xiang J. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4\/SOX2 Axis. Anal Cell Pathol (Amsterdam). 2022;2022(1):5632164.","journal-title":"Anal Cell Pathol (Amsterdam)"},{"issue":"2","key":"3004_CR84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.devcel.2009.12.013","volume":"18","author":"R Baumgartner","year":"2010","unstructured":"Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 2010;18(2):309\u201316.","journal-title":"Dev Cell"},{"issue":"2","key":"3004_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.devcel.2009.12.011","volume":"18","author":"A Genevet","year":"2010","unstructured":"Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador\/Warts\/Hippo signaling network. Dev Cell. 2010;18(2):300\u20138.","journal-title":"Dev Cell"},{"issue":"1","key":"3004_CR86","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1038\/ncomms7411","volume":"6","author":"U Basu-Roy","year":"2015","unstructured":"Basu-Roy U, Bayin NS, Rattanakorn K, Han E, Placantonakis DG, Mansukhani A, et al. Sox2 antagonizes the hippo pathway to maintain stemness in cancer cells. Nat Commun. 2015;6(1):6411.","journal-title":"Nat Commun"},{"issue":"14","key":"3004_CR87","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.febslet.2012.03.023","volume":"586","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J, Xi Q. TGF-\u03b2 control of stem cell differentiation genes. FEBS Lett. 2012;586(14):1953\u20138.","journal-title":"FEBS Lett"},{"issue":"5","key":"3004_CR88","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","volume":"160","author":"N Oshimori","year":"2015","unstructured":"Oshimori N, Oristian D, Fuchs E. TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell. 2015;160(5):963\u201376.","journal-title":"Cell"},{"issue":"5","key":"3004_CR89","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.stem.2009.08.018","volume":"5","author":"H Ikushima","year":"2009","unstructured":"Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K. Autocrine TGF-\u03b2 signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell. 2009;5(5):504\u201314.","journal-title":"Cell Stem Cell"},{"issue":"48","key":"3004_CR90","doi-asserted-by":"publisher","first-page":"41434","DOI":"10.1074\/jbc.M111.300863","volume":"286","author":"H Ikushima","year":"2011","unstructured":"Ikushima H, Todo T, Ino Y, Takahashi M, Saito N, Miyazawa K, et al. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein. J Biol Chem. 2011;286(48):41434\u201341.","journal-title":"J Biol Chem"},{"issue":"6","key":"3004_CR91","first-page":"3395","volume":"42","author":"Z Liu","year":"2018","unstructured":"Liu Z, Kuang W, Zhou Q, Zhang Y. TGF-\u03b21 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2\/3 signalling pathway. Int J Mol Med. 2018;42(6):3395\u2013403.","journal-title":"Int J Mol Med"},{"key":"3004_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07081-z","volume":"20","author":"P-A Bissey","year":"2020","unstructured":"Bissey P-A, Teng M, Law JH, Shi W, Bruce JP, Petit V, et al. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer. 2020;20:1\u201313.","journal-title":"BMC Cancer"},{"issue":"1","key":"3004_CR93","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.oraloncology.2014.10.002","volume":"51","author":"M-Y Chou","year":"2015","unstructured":"Chou M-Y, Hu F-W, Yu C-H, Yu C-C. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. Oral Oncol. 2015;51(1):31\u20139.","journal-title":"Oral Oncol"},{"issue":"1","key":"3004_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-6-91","volume":"6","author":"H Wang","year":"2006","unstructured":"Wang H, Zhao L-N, Li K-Z, Ling R, Li X-J, Wang L. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer. 2006;6(1):1\u20138.","journal-title":"BMC Cancer"},{"key":"3004_CR95","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S177373","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang P, Shao M, Zang X, Zhang J, Mao F, et al. SALL4 activates TGF-\u03b2\/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis. Cancer Manag Res. 2018. https:\/\/doi.org\/10.2147\/CMAR.S177373.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"3004_CR96","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.21037\/tcr.2020.04.13","volume":"9","author":"Y Ma","year":"2020","unstructured":"Ma Y, Xue H, Wang W, Yuan Y, Liang F. The miR-567\/RPL15\/TGF-\u03b2\/Smad axis inhibits the stem-like properties and chemo-resistance of gastric cancer cells. Transl Cancer Res. 2020;9(5):3539.","journal-title":"Transl Cancer Res"},{"key":"3004_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155683","volume":"263","author":"F Tolue Ghasaban","year":"2024","unstructured":"Tolue Ghasaban F, Moghbeli M. Long non-coding RNAs as the pivotal regulators of epithelial mesenchymal transition through WNT\/beta-catenin signaling pathway in tumor cells. Pathol Res Pract. 2024;263: 155683.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"3004_CR98","first-page":"594","volume":"26","author":"Z Nasrpour Navaei","year":"2023","unstructured":"Nasrpour Navaei Z, Taghehchian N, Zangouei AS, Abbaszadegan MR, Moghbeli M. Microrna-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways. Iran J Basic Med Sci. 2023;26(5):594\u2013602.","journal-title":"Iran J Basic Med Sci"},{"issue":"18","key":"3004_CR99","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/onc.2011.405","volume":"31","author":"U Basu-Roy","year":"2012","unstructured":"Basu-Roy U, Seo E, Ramanathapuram L, Rapp TB, Perry JA, Orkin SH, et al. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene. 2012;31(18):2270\u201382.","journal-title":"Oncogene"},{"issue":"22","key":"3004_CR100","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1128\/MCB.05798-11","volume":"31","author":"E Seo","year":"2011","unstructured":"Seo E, Basu-Roy U, Zavadil J, Basilico C, Mansukhani A. Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol. 2011;31(22):4593\u2013608.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3004_CR101","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/mmr.2017.6170","volume":"15","author":"J He","year":"2017","unstructured":"He J, Shi J, Zhang K, Xue J, Li J, Yang J, et al. Sox2 inhibits Wnt-\u03b2-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells. Mol Med Rep. 2017;15(4):1693\u2013701.","journal-title":"Mol Med Rep"},{"issue":"4","key":"3004_CR102","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/cas.13186","volume":"108","author":"Y Wen","year":"2017","unstructured":"Wen Y, Hou Y, Huang Z, Cai J, Wang Z. SOX 2 is required to maintain cancer stem cells in ovarian cancer. Cancer Sci. 2017;108(4):719\u201331.","journal-title":"Cancer Sci"},{"issue":"9","key":"3004_CR103","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ncb3394","volume":"18","author":"Y Tang","year":"2016","unstructured":"Tang Y, Feinberg T, Keller ET, Li X-Y, Weiss SJ. Snail\/Slug binding interactions with YAP\/TAZ control skeletal stem cell self-renewal and differentiation. Nat Cell Biol. 2016;18(9):917\u201329.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"3004_CR104","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/15384101.2017.1280643","volume":"16","author":"Y Tang","year":"2017","unstructured":"Tang Y, Weiss SJ. Snail\/Slug-YAP\/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation. Cell Cycle. 2017;16(5):399\u2013405.","journal-title":"Cell Cycle"},{"key":"3004_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104948","volume":"111","author":"JH Moon","year":"2020","unstructured":"Moon JH, Lee SH, Koo BS, Kim JM, Huang S, Cho JH, et al. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells. Oral Oncol. 2020;111: 104948.","journal-title":"Oral Oncol"},{"issue":"14","key":"3004_CR106","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1158\/0008-5472.CAN-09-0654","volume":"69","author":"M Munz","year":"2009","unstructured":"Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 2009;69(14):5627\u20139.","journal-title":"Cancer Res"},{"key":"3004_CR107","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","volume":"39","author":"O Gires","year":"2020","unstructured":"Gires O, Pan M, Schinke H, Canis M, Baeuerle PA. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? Cancer Metastasis Rev. 2020;39:969\u201387.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"3004_CR108","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1002\/jcp.29252","volume":"235","author":"D Zhang","year":"2020","unstructured":"Zhang D, Yang L, Liu X, Gao J, Liu T, Yan Q, et al. Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells. J Cell Physiol. 2020;235(4):3626\u201333.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3004_CR109","doi-asserted-by":"publisher","first-page":"41852","DOI":"10.1038\/srep41852","volume":"7","author":"I-I Kuan","year":"2017","unstructured":"Kuan I-I, Liang K-H, Wang Y-P, Kuo T-W, Meir Y-JJ, Wu SC-Y, et al. EpEX\/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2\u03b1. Sci Rep. 2017;7(1):41852.","journal-title":"Sci Rep"},{"issue":"2","key":"3004_CR110","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/ijms24021062","volume":"24","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang N, Chen Q, Feng Q, Zhang Y, Wang Z, et al. SNAI2 attenuated the stem-like phenotype by reducing the expansion of EPCAMhigh cells in cervical cancer cells. Int J Mol Sci. 2023;24(2):1062.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3004_CR111","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ijc.31338","volume":"143","author":"S Jiang","year":"2018","unstructured":"Jiang S, Li T, Yang Z, Hu W, Yang Y. Deciphering the roles of FOXO1 in human neoplasms. Int J Cancer. 2018;143(7):1560\u20138.","journal-title":"Int J Cancer"},{"key":"3004_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0894-0","volume":"37","author":"S Cao","year":"2018","unstructured":"Cao S, Wang Z, Gao X, He W, Cai Y, Chen H, et al. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. J Exp Clin Cancer Res. 2018;37:1\u201312.","journal-title":"J Exp Clin Cancer Res"},{"issue":"34","key":"3004_CR113","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1038\/onc.2011.541","volume":"31","author":"L Li","year":"2012","unstructured":"Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt\/\u03b2-catenin signaling and silenced in common carcinomas. Oncogene. 2012;31(34):3901\u201312.","journal-title":"Oncogene"},{"issue":"1","key":"3004_CR114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23\u201338.","journal-title":"Neuropsychopharmacology"},{"issue":"33","key":"3004_CR115","doi-asserted-by":"publisher","first-page":"24234","DOI":"10.1074\/jbc.M113.469783","volume":"288","author":"RT Sussman","year":"2013","unstructured":"Sussman RT, Stanek TJ, Esteso P, Gearhart JD, Knudsen KE, McMahon SB. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). J Biol Chem. 2013;288(33):24234\u201346.","journal-title":"J Biol Chem"},{"issue":"4","key":"3004_CR116","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1172\/JCI91144","volume":"127","author":"N Li","year":"2017","unstructured":"Li N, Xue W, Yuan H, Dong B, Ding Y, Liu Y, et al. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. J Clin Invest. 2017;127(4):1284\u2013302.","journal-title":"J Clin Invest"},{"issue":"1","key":"3004_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9010002","volume":"9","author":"S Janczar","year":"2017","unstructured":"Janczar S, Janczar K, Pastorczak A, Harb H, Paige AJ, Zalewska-Szewczyk B, et al. The role of histone protein modifications and mutations in histone modifiers in pediatric B-cell progenitor acute lymphoblastic leukemia. Cancers. 2017;9(1): 2.","journal-title":"Cancers"},{"key":"3004_CR118","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S276168","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Lin S, Wu X, Xu J, Li L, Ye W, et al. Decitabine and Cisplatin are synergistic to exert anti-tumor effect on gastric cancer via inducing Sox2 DNA demethylation. OncoTargets Ther. 2021. https:\/\/doi.org\/10.2147\/OTT.S276168.","journal-title":"OncoTargets Ther"},{"issue":"8","key":"3004_CR119","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569\u201379.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3004_CR120","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/epr.09.17","volume":"6","author":"RJ Simpson","year":"2009","unstructured":"Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 2009;6(3):267\u201383.","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"3004_CR121","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2019;1871(2):455\u201368.","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"issue":"3","key":"3004_CR122","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345.","journal-title":"Mol Cell"},{"issue":"4","key":"3004_CR123","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","volume":"155","author":"J-M Fustin","year":"2013","unstructured":"Fustin J-M, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155(4):793\u2013806.","journal-title":"Cell"},{"issue":"6","key":"3004_CR124","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254\u201370.","journal-title":"Hepatology"},{"issue":"1","key":"3004_CR125","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","volume":"29","author":"H Xie","year":"2022","unstructured":"Xie H, Yao J, Wang Y, Ni B. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis. Drug Deliv. 2022;29(1):1257\u201371.","journal-title":"Drug Deliv"},{"issue":"5","key":"3004_CR126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13(5):343\u201357.","journal-title":"Nat Rev Genet"},{"issue":"20","key":"3004_CR127","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/emboj.2011.295","volume":"30","author":"A Pekowska","year":"2011","unstructured":"Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J. 2011;30(20):4198\u2013210.","journal-title":"EMBO J"},{"issue":"7163","key":"3004_CR128","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007;449(7163):731\u20134.","journal-title":"Nature"},{"issue":"1","key":"3004_CR129","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/etm.2021.10155","volume":"22","author":"L Liu","year":"2021","unstructured":"Liu L, Liu J, Lin Q. Histone demethylase KDM2A: biological functions and clinical values (review). Exp Ther Med. 2021;22(1):723.","journal-title":"Exp Ther Med"},{"issue":"19","key":"3004_CR130","doi-asserted-by":"publisher","first-page":"27689","DOI":"10.18632\/oncotarget.8381","volume":"7","author":"J-Y Chen","year":"2016","unstructured":"Chen J-Y, Li C-F, Chu P-Y, Lai Y-S, Chen C-H, Jiang SS, et al. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1. Oncotarget. 2016;7(19):27689.","journal-title":"Oncotarget"},{"key":"3004_CR131","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S166006","author":"X Han","year":"2018","unstructured":"Han X, Piao L, Zhuang Q, Yuan X, Liu Z, He X. The role of histone lysine methyltransferase NSD3 in cancer. OncoTargets Ther. 2018. https:\/\/doi.org\/10.2147\/OTT.S166006.","journal-title":"OncoTargets Ther"},{"issue":"4","key":"3004_CR132","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","volume":"44","author":"AJ Kuo","year":"2011","unstructured":"Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell. 2011;44(4):609\u201320.","journal-title":"Mol Cell"},{"issue":"2","key":"3004_CR133","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41419-019-1347-1","volume":"10","author":"C He","year":"2019","unstructured":"He C, Liu C, Wang L, Sun Y, Jiang Y, Hao Y. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma. Cell Death Dis. 2019;10(2):65.","journal-title":"Cell Death Dis"},{"issue":"7286","key":"3004_CR134","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature08788","volume":"464","author":"D Pasini","year":"2010","unstructured":"Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature. 2010;464(7286):306\u201310.","journal-title":"Nature"},{"key":"3004_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-018-0217-x","volume":"11","author":"A Adhikari","year":"2018","unstructured":"Adhikari A, Davie J. JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling. Epigenetics Chromatin. 2018;11:1\u201320.","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"3004_CR136","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.molcel.2019.12.019","volume":"77","author":"S Chen","year":"2020","unstructured":"Chen S, Jiao L, Liu X, Yang X, Liu X. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin. Mol Cell. 2020;77(6):1265\u201378.","journal-title":"Mol Cell."},{"key":"3004_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106040","volume":"138","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wu J, Wei H, Huang H, Huang Y, Fang H, et al. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1. Int J Biochem Cell Biol. 2021;138: 106040.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"3004_CR138","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01626-3","volume":"39","author":"T-y Chen","year":"2022","unstructured":"Chen T-y, Zhou J, Li P-c, Tang C-h, Xu K, Li T, et al. SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling. Med Oncol. 2022;39(3): 36.","journal-title":"Med Oncol"},{"issue":"4","key":"3004_CR139","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1089\/ars.2013.5492","volume":"20","author":"M Li","year":"2014","unstructured":"Li M, Wilson DM III. Human apurinic\/apyrimidinic endonuclease 1. Antioxid Redox Signal. 2014;20(4):678\u2013707.","journal-title":"Antioxid Redox Signal"},{"key":"3004_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1294-9","volume":"38","author":"MC Malfatti","year":"2019","unstructured":"Malfatti MC, Gerratana L, Dalla E, Isola M, Damante G, Di Loreto C, et al. APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC. J Exp Clin Cancer Res. 2019;38:1\u201323.","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"3004_CR141","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1093\/nar\/gkx693","volume":"45","author":"J Taniguchi","year":"2017","unstructured":"Taniguchi J, Pandian GN, Hidaka T, Hashiya K, Bando T, Kim KK, et al. A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm. Nucleic Acids Res. 2017;45(16):9219\u201328.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3004_CR142","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5(1):135.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3004_CR143","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7150\/jca.88397","volume":"15","author":"Y Ding","year":"2024","unstructured":"Ding Y, Wang H, Wang Q, Jiang H, Li Z, Yu Z, et al. Pan-cancer analysis reveals SOX2 as a promising prognostic and immunotherapeutic biomarker across various cancer types, including pancreatic cancer. J Cancer. 2024;15(1):251\u201374.","journal-title":"J Cancer"},{"issue":"1","key":"3004_CR144","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-016-0534-2","volume":"15","author":"Y Miyazaki","year":"2016","unstructured":"Miyazaki Y, Matsubara S, Ding Q, Tsukasa K, Yoshimitsu M, Kosai K, et al. Efficient elimination of pancreatic cancer stem cells by hedgehog\/GLI inhibitor GANT61 in combination with mTOR inhibition. Mol Cancer. 2016;15(1):49.","journal-title":"Mol Cancer"},{"issue":"1","key":"3004_CR145","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41413-024-00395-9","volume":"13","author":"Y Liu","year":"2025","unstructured":"Liu Y, Kang L, Luo J, Yang M, Wang D, Ye J, et al. Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma. Bone Res. 2025;13(1):25.","journal-title":"Bone Res"},{"key":"3004_CR146","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1476-4598-11-73","volume":"11","author":"S Singh","year":"2012","unstructured":"Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, et al. EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer. 2012;11:73.","journal-title":"Mol Cancer"},{"issue":"32","key":"3004_CR147","first-page":"2548","volume":"96","author":"B Wei","year":"2016","unstructured":"Wei B, Liu G, Cai HL, Li GP, Huang HQ, Luo Q, et al. Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells. Zhonghua Yi Xue Za Zhi. 2016;96(32):2548\u201353.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"3004_CR148","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.celrep.2013.09.018","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, Lu F, Wang J, Yin F, Xu Z, Qi D, et al. Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells. Cell Rep. 2013;5(2):445\u201357.","journal-title":"Cell Rep"},{"issue":"41","key":"3004_CR149","doi-asserted-by":"publisher","first-page":"20528","DOI":"10.1073\/pnas.1905973116","volume":"116","author":"Y Yin","year":"2019","unstructured":"Yin Y, Xie CM, Li H, Tan M, Chen G, Schiff R, et al. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells. Proc Natl Acad Sci U S A. 2019;116(41):20528\u201338.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3004_CR150","doi-asserted-by":"publisher","first-page":"19298","DOI":"10.1002\/jcp.28610","volume":"234","author":"EP Metz","year":"2019","unstructured":"Metz EP, Rizzino A. Sox2 dosage: a critical determinant in the functions of Sox2 in both normal and tumor cells. J Cell Physiol. 2019;234(11):19298\u2013306.","journal-title":"J Cell Physiol"},{"issue":"Pt 1","key":"3004_CR151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak D, Huser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67(Pt 1):74\u201382.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3004_CR152","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41467-024-55223-9","volume":"16","author":"F Millozzi","year":"2025","unstructured":"Millozzi F, Milan-Rois P, Sett A, Delli Carpini G, De Bardi M, Gisbert-Garzaran M, et al. Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles. Nat Commun. 2025;16(1):577.","journal-title":"Nat Commun"},{"key":"3004_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184540","author":"S Mercurio","year":"2019","unstructured":"Mercurio S, Serra L, Nicolis SK. More than just stem cells: functional roles of the transcription factor Sox2 in differentiated glia and neurons. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184540.","journal-title":"Int J Mol Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T19:02:41Z","timestamp":1758135761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":153,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03004-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"437"}}